Диссертация (1174352), страница 19
Текст из файла (страница 19)
Long-term outcome after ischaemic stroke/transientischaemic attack // Cerebrovasc. Dis. - 2003. - Vol. 16(suppl. 1). - P. 14-19.152. Harker L.A. Therapeutic inhibition of platelet function in stroke //Cerebrovasc. Dis. - 1998. - Vol. 8(suppl. 5). - P. 8-18.153. Heagerty A.M. Angiotensin II: vasoconstrictor or growth factor? // J.Cardiovasc. Pharmacol. - 1991.
- Vol. 18(2). - P. 14-19.154. Helgadottir A., Manolescu A., Thorleifsson G. et al. The gene encoding 5lipoxygenase activating protein confers risk of myocardial infarction and stroke // Natl.Genet. - 2004. - Vol. 36(3). - P. 233-239.155. Helgadottir A., Thorleifsson G., Manolescu A. et al. A common variant onchromosome 9p21 affects the risk of myocardial infarction // Science. - 2007. - Vol.316(5830).
- P. 1491-1493.156. Hindorff L.A., Schwartz S.M., Siscovick D.S. et al. The association ofPAI-1 promoter 4G/5G insertion/ deletion polymorphism with myocardial infarctionand stroke in young women // J. Cardiovasc. Risk. - 2002. - Vol. 9(2). - P. 131-137.157. Hou L., Osei-Hyiaman D., Yu H., et al. Association of a 27-bp repeatpolymorphism in ecNOS gene with ischemic stroke in Chinese patients // Neurology. 2001.
- №4. - P. 490-6.158.Houslay M.D., Adams D.R. PDE4 cAMP phosphodiesterases: modularenzymes that orchestrate signaling cross-talk, desensitization and compartmentalization// Biochem. J. - 2003. - Vol. 370(Pt 1). - P. 1-18.159. Howard G., Wagenknecht L.E., Cai J. et al. Cigarette smoking and otherrisk factors for silent cerebral infarction in the general population // Stroke. - 1998. Vol.
29(5). - P. 913-917.160. Hsieh K., Funk M., Schillinger M., et al. Vienna Stroke Registry, impact ofthe platelet glycoprotein Ib alpha Kozak polymorphism on the risk of ischemiccerebrovascular events: a case-control study // Blood Coagul Fibrinolysis. - 2004. №15. - P. 469–73.114115161.Hsieh M.S., Yu S.C., Chung W.T. et al. Phosphodiesterase 4D (PDE4D)gene variants and risk of ischemic stroke in the Taiwanese population // Lab. Medicine.- 2009.
- Vol. 40(2). - P. 87-90.162. Ikram M.A., Seshadri S., Bis J.C. et al. Genomewide association studies ofstroke // N. Engl. J. Med. - 2009. - Vol. 360(17). - P. 1718-1728.163. Isozumi K. Obesity as a risk factor for cerebrovascular disease // Keio J.Med. - 2004. - Vol. 53(1).
- P. 7-11.164.JacobC.,Martin-ChoulyC.,LagenteV.Type4phosphodiesterasedependent pathways: Role in inflammatory processes // Therapie. 2002. - Vol. 57(2). - P. 163168.165.Jerrard-Dunne P., Cloud G., Hassan A., Markus H.S. Evaluating thegenetic component of ischemic stroke subtypes: a family history study // Stroke.
- 2003.- Vol. 34 (6). - P. 1364–1369.166. Joutel A., Chabriat H., Vahedi K. et al. Splice site mutation causing a sevenamino acid Notch3 in-frame deletion in CADASIL // Neurology. - 2000. Vol. 54(9). - P.1874-1875.167. Joutel A., Corpechot C., Ducros A. et al. Notch3 mutations in CADASIL, ahereditary adult-onset condition causing stroke and dementia // Nature. - 1996.
- Vol.383 (6602). - P. 707–710.168.Joutel A., Ducros A., Alamowitch S. A human homolog of bacterialacetolactate synthase genes maps within the CADASIL critical region // Genomics. 1996. - Vol. 38(2). - P. 192-198.169. Kamberi B1, Kamberi F2, Spiroski M3.Vascular Genetic Variants andIschemic Stroke Susceptibility in Albanians from the Republic of Macedonia // OpenAccess Maced J Med Sci.
- 2016. - №4. - P. 556-564.170. Kanaji T., Okamura T., Osaki K. et al. A common genetic polymorphism :46 C to T substitution) in the 5’-untranslated region of the coagulation factor XII gene isassociated with low translation efficiency and decrease in plasma factor XII level //Blood.
- 1998. - №6. - P. 2010—2014.171. Kane W.H., Davie E.W. Blood coagulation factors V and VIII: structuraland functional similarities and their relationship to hemorrhagic and thromboticdisorders // Blood. - 1988. - Vol. 71(3). - P. 539-555.115116172. Kannel W.B., D'Agostino R.B., Belanger A.J. Fibrinogen, cigarettesmoking, and risk of cardiovascular disease: insights from the Framingham Study //Am. Heart.
J. - 1987. - Vol. 113(4). - P. 1006-1010.173. Karagiannis A., Balaska K., Tziomalos K. et al. Lack of an associationbetween angiotensin converting enzyme gene polymorphism and peripheral arterialocclusive disease // Vase. Med. - 2004. - Vol. 9(3). - P. 189-192.174. Kaushal R., Pal P., Alwell K. et al. Association of ALOX5AP withischemic stroke: a population-based case-control study // Hum. Genet. - 2007. - Vol.121(5). - P.
601607.175. Kohler H.P., Grant PJ. Plasminogen-activator inhibitor type 1 and coronaryartery disease // N. Engl. J. Med. - 2000. - Vol. 342(24). - P. 1792-1801.176. Kooperberg C., Bis J.C., Marciante K.D., Heckbert S.R.,Lumley T., PsatyB.M. Logic regression for analysis of the association between genetic variation in thereninangiotensin system and myocardial infarction or stroke // Am. J. Epidemiol. 2007. - №165. - P. 334–343.177. Kostulas K., Gretarsdottir S., Kostulas V. et al. PDE4D and ALOX5APgenetic variants and risk for Ischemic Cerebrovascular Disease in Sweden // J. Neurol.Sci. - 2007. - Vol. 263(1-2). - P.
113-117.178. Kunicki T. J., Orchekowski R., Annis D. et al. Variability of integrin alpha2 beta 1 activity on human platelets // Blood. - 1993. - Vol. 82. - P. 2693 - 2703.179. Kunicki T. J., Williams S. A., Salomon D. R., Harrison P., Crisler P.,Nakagawa P., Mondala T. S., Head S. R., Nugent D. J. Genetics of platelet reactivity innormal, healthy individuals // Journal of thrombosis and haemostasis: JTH. - 2009. №7. - P.
2116-2122.180. Lalouschek W., Endler G., Schillinger M. et al. Candidate genetic riskfactors of stroke: results of a multilocus genotyping assay // Clin. Chem. - 2007. - Vol.53(4). - P. 600-605.181. Lane D.A., Grant P.J. Role of hemostatic gene polymorphisms in venousand arterial thrombotic disease // Blood. - 2000. - Vol. 95(5). - P. 1517-1532.182.
Libby P. Inflammation in atherosclerosis // Nature. - 2002. - Vol.420(6917). - P. 868-874.116117183. Liu H., Xia P., Liu M. et al. PON gene polymorphisms and ischaemicstroke: a systematic review and meta-analysis // Int. J. Stroke. - 2013. - Vol. 8 (2).
- P.111–123.184. Liu X, Zhu R, Li L, Deng S, Li Q, He Z. Genetic polymorphism in PDE4Dgene and risk of ischemic stroke in Chinese population: a meta-analysis // PLoS One. 2013. - №8(6).185. Lloyd-Jones, D. Heart Disease and Stroke Statistics: A Report From theAmerican Heart Association Statistics Committee and Stroke Statistics Subcommittee //Circulation. - 2009.
- № 119. - P. 21-181.186. Lopez J.A., Leung B., Reynolds C.C. et al. Efficient plasma membraneexpression of a functional platelet glycoprotein Ib-IX complex requires the presence ofits three subunits // J. Biol. Chem. - 1992. - Vol. 267(18). - P. 12851-12859.187. Lusis A. J. Genetic factors in cardiovascular disease.
10 questions // TrendsCardiovasc. Med. - 2003. - N 8. - P. 309-316.188. Lusis A.J. Atherosclerosis // J Nature. - 2000. - №68. - P. 233–241.189. Marciante K.D., Bis J.C., Rieder M.J., Reiner A.P., Lumley T., MonksS.A., Kooperberg C., Carlson C.,Heckbert S.R., Psaty B.M. Renin_angiotensin systemhaplotypes and the risk of myocardial infarctionand stroke in pharmacologically treatedhypertensive patients // Am. J. Epidemiol. - 2007. - №166. - P. 19–27.190. MarcusH.,HambleyH.Neurologysndblood:haematologicalabnormalities in ischemic stroke // J.
neurol. Neuroserg. Psychiatry. - 1998. - Vol. 64. P. 150-159.191. Matarin M., Brown W.M., Dena H., et al. Candidate gene polymorphismsfor ischemic stroke // Stroke. - 2009. - №40. - P. 3436–3442.192. Mendall M.A. et al Relation of serum cytokine concentrations tocardiovascular risk factors and coronary heart disease // Heart. - 1997. - Vol. 78. P.273-277.193.
Meschia J.F., Brott T.G., Brown R.D. Jr. Genetics of cerebrovasculardisorders //Mayo Clin. Proc. - 2005. - Vol. 80 (1). - P. 122–32.194. Meschia JF, Brott TG, Brown RD Jr, Crook R, Worrall BB, Kissela B,Brown WM, Rich SS, Case LD, Evans EW, Hague S, Singleton A, Hardy J; SWISSStudy Group; ISGS Study Group; MSGD Study Group. Phosphodiesterase 4D and 5117118lipoxygenase activating protein in ischemic stroke.
// Ann Neurol. - 2005. - Vol. 58(3). P. 351-61.195. Miyahara K., Kawamoto T., Sase K., et al. Cloning and structuralcharacterization of the human endothelial nitric-oxide-synthase gene // Eur J Biochem. 1994. - №3. - P. 719-26.196. Moroi M., Jung S.M., Yoshida N. Genetic polymorphism of plateletglycoprotein lb // Blood. - 1984. - Vol. 64(3).
- P. 622-629.197.Munshi A., Kaul S. Stroke genetics focus on PDE4D gene // Int. J. Stroke.- 2008. - Vol. 3(3). - P. 188-192.198. Neter J.E., Stam B.E., Kok F.J. et al. Influence of weight reduction onblood pressure: a meta-analysis of randomized controlled trials // Hypertension. - 2003.- Vol. 42(5). - P.
878-884.199. Nicolaes G.A., Dahlback B. Factor V and thrombotic disease: descriptionof a janus-faced protein // Arterioscler. Thromb. Vase. Biol. - 2002. -Vol. 22(4). - P.530-538.200.Nilsson-Ardnor S., Wiklund P.G., Lindgren P. et al. Linkage of ischemicstroke to the PDE4D region on 5q in a Swedish population // Stroke. - 2005.
- Vol.36(8). - P. 1666-1671.201. Owen C.A. Jr., Bowie E.J. Generation of coagulation factors V, XI, andXII by the isolated rat liver // Haemostasis. - 1977. - Vol. 6(4). - P. 205-212.202. Pera J., Slowik A., Dziedzic T. ACE I/D polymorphism in differentetiologies of ischemic stroke // Acta Neurol. Scand.
- 2006. - Vol. 114(5). - P. 320-322.203. Peterson D.M., Stathopoulos N.A., Giorgio T.D. et al. Shear-inducedplatelet aggregation requires von Willebrand factor and platelet glycoproteins lb andIlb-IIIa // Blood. - 1987. - Vol. 69(2). - P. 625- 628.204.Petrovic D., Milanez T., Kobal J. et al. Prothrombotic gene polymorphismsand atherothrombotic cerebral infarction // Acta. Neurol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
